Hedge Crunch FinancialValeant Pharmaceuticals
Ackman’s Pershing Square Sells Off Valeant Stock
Pershing Square Capital Management, Bill Ackman’s hedge fund, has sold some of its many shares in Valeant Pharmaceuticals. Valeant is the drug company which Ackman valiantly defended in 2015, backing up his support with considerable quantities of money. Last November Pershing owned close to 10 percent of Valeant, up from the 5.7 percent of shares […]